A1M Pharma AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Gunnar Telhammar, was filed 31 May 2019.
A1M Pharma AB: what insiders have been doing
This page follows insider dealings at A1M Pharma AB as filed with Finansinspektionen. The past year has been quiet: not a single insider filing for A1M Pharma AB. The previous disclosure was published on 25 October 2019.
The full history, which starts in 2017, counts 10 purchases against no sales.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
- 12,188 shares@ SEK 1.0027.7% of flowAktieISIN SE0009973357FI:csv-ddb37c60b50887b6643e
- 12,188 shares0TeckningsoptionISIN SE0012230696FI:csv-e4f5ba108386309b450a
- 196,080 shares@ SEK 1.00100.0% of flowTeckningsoptionISIN SE0012230696FI:csv-117b33e1d75689be7007
- 20,000 shares@ SEK 1.0348.1% of flowAktieISIN SE0009973357FI:csv-51eb1ab8eac203f0614eCanonical exit: 29 Aug 2019 (T+90)
- 6,000 shares@ SEK 0.030.4% of flowTeckningsrättISIN SE0012230712FI:csv-e556f95257679b85557bCanonical exit: 16 May 2019 (T+90)
- 2,000 shares@ SEK 10.2048.1% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-de52d1f35e914d95c09b
- 141 shares@ SEK 10.203.4% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-792543f1912ee87861f9Canonical exit: 16 May 2019 (T+90)
- 10,562 shares@ SEK 10.2063.1% of flowBTU (betald tecknad unit)ISIN SE0009973357FI:csv-bb10c149984960a988b0Canonical exit: 14 May 2019 (T+90)
- 1,961 shares@ SEK 10.20100.0% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-8fa70946d7ae4def0127Canonical exit: 15 May 2019 (T+90)
- 3,047 shares@ SEK 10.2072.3% of flowBTU (betald tecknad unit)ISIN SE0012230720FI:csv-ce1a966fcce70763d37f
- 12,078 shares@ SEK 5.0036.9% of flowISIN SE0010948372FI:csv-40b510ade3253c5d9478Canonical exit: 19 Jun 2018 (T+90)
- 20,000 shares@ SEK 5.0085.3% of flowISIN SE0010948372FI:csv-821803d72fa4c7c18aacCanonical exit: 19 Jun 2018 (T+90)
- 12,000 shares@ SEK 5.00100.0% of flowISIN SE0010948372FI:csv-4c580ec9a77aa0933971Canonical exit: 21 Jun 2018 (T+90)
- 30,000 shares@ SEK 5.00100.0% of flowISIN SE0010948372FI:csv-2cc207325737c66eb9bb
- 22,843 shares0ISIN SE0009773450FI:csv-47ecf69ada904359c2ad
- 1,142 shares@ SEK 15.0014.7% of flowISIN SE0009973357FI:csv-e9d0144d25a05b004a27
- 44,444 shares0ISIN SE0009773450FI:csv-13cd6f7005c1d02348d2
- 2,222 shares@ SEK 15.000.0% of flowISIN SE0009973357FI:csv-1c6e5dadee51cecbcc76
- 40,000 shares0ISIN SE0009773450FI:csv-fe0851d883999f94e152
- 2,000 shares@ SEK 15.000.0% of flowISIN SE0009973357FI:csv-089571478682918ad859
- 44,444 shares@ SEK 99,999.00100.0% of flowISIN SE0009773435FI:csv-262e58d9ec002fbf5852Canonical exit: 6 Jul 2017 (T+90)
- 40,000 shares@ SEK 90,000.00100.0% of flowISIN SE0009773435FI:csv-4c3ef4d0d90852f9d308Canonical exit: 6 Jul 2017 (T+90)
22 of 22 declarations
About A1M Pharma AB
A1M Pharma AB is a biopharmaceutical company focused on developing treatments for diseases related to inflammation and ischemia. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations